VEGFA and neoplasm: Thus, neoadjuvant therapy using these drugs may decrease tumor size, reduce the stage or extent of tumor before attempting surgical control, or improve the results of surgery, although no association was found between survival and overexpression of VEGF-A or PDGF-B in the current study.